Sodium dodecyl sulfate stability of HLA-DR1 complexes correlates with burial of hydrophobic residues in pocket 1

Journal of Immunology

Volumn 162, Issue 6, 1999, Pages 3463-3470

  Natarajan, Sateesh K ^a   Stern, Lawrence J ^b   Sadegh Nasseri, Scheherazade ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DODECYL SULFATE SODIUM; HLA DR1 ANTIGEN;

AMINO ACID ANALYSIS; ARTICLE; GEL FILTRATION; HYDROPHOBICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN STRUCTURE;

EID: 0033559513     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Springer, T. A., J. F. Kaufman, L. A. Siddoway, D. L. Mann, and J. L. Strominger, 1977. Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. J. Biol. Chem. 252:6201.
2. Dornmair, K., B. Rothenhausler, and H. M. McConnell. 1989. Structural intermediates in the reactions of antigenic peptides with MHC molecules. Cold Spring Harb. Symp. Quant. Biol. 1:409.
3. Sadegh-Nasseri, S., and R. N. Germain. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
4. Stern, L. J., and D. C. Wiley. 1992. The human class II MHC protein HLA-DRI assembles as empty αβ heterodimers in the absence of antigenic peptide. Cell 68:465.
5. Sadegh-Nasseri, S., L. J. Stern, D. C. Wiley, and R. N. Germain. 1994. MHC class II function preserved by low-affinity peptide interactions preceding stable binding. Nature 370:647.
6. Sadegh-Nasseri, S., and R. N. Germain. 1992 How MHC class II molecules work: peptide-dependent completion of protein folding. Immunol. Today 13:43.
7. West, M. A., J. M. Lucocq, and C. Watts. 1994 Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 169:147.
8. Amigorena, S., J. R. Drake, P. Webster, and J. Mellman. 1994. Transient accumulation of new class II MHC molecules in a novel endocytic compartment in B lymphocytes. Nature 369:113.
9. Tulp, A., D. Verwoerd, B. Dobberstein, H. L. Ploegh, and J. Pieters. 1994. Isolation and characterization of the intracellular MHC class II compartment. Nature 369:120.
10. Qiu, Y., X. Xu, A. Wandinger-Ness, D. P. Dalke, and S. K. Pierce. 1994. Separation of subcellular compartments containing distinct functional forms of MHC class II. J. Cell Biol. 125:595.
11. Castellino, F., and R. N. Germain. 1995. Extensive trafficking of MHC class II-invariant chain complexes in the endocytic pathway and appearance of peptide-loaded class II in multiple compartments. Immunity 2:73.
12. Amigorena, S., P. Webster, J. Drake, J. Newcomb, P. Cresswell, and I. Mellman. 1995. Invariant chain cleavage and peptide loading in major histocompatibility complex class II vesicles. J. Exp. Med. 181:1729.
13. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
14. Germain, R. N., and A. Rinker, Jr. 1993. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules. Nature 363:725.
15. Germain, R. N., and L. R. Hendrix. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
16. Avva, R. R., and P. Cresswell. 1994. In vivo and in vitro formation and dissociation of HLA-DR complexes with invariant chain-derived peptides. Immunity 1:763
17. Denzin, L. K., N. F. Robbins, C. Carboy-Newcomb, and P. Cresswell. 1994. Assembly and intracellular transport of HLA-DM and correction of the class II antigen-processing defect in T2 cells. Immunity 1:595.
18. Denzin, L. K., and P. Cresswell 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell 82:155.
19. Riese, R. J., P. R. Wolf, D. Bromme, L. R. Natkin, J. A. Villadangos, H. L. Ploegh, and H. A. Chapman. 1996. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 4:357.
20. Neefjes, J. J., and H. L. Ploegh. 1992. Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistant αβ heterodimers in endosomes. EMBO J. 11:411.
21. Benaroch, P., M. Yilla, G. Raposo, K. Ito, K. Miwa, H. J. Geuze, and H. L. Ploegh. 1995. How MHC class II molecules reach the endocytic pathway. EMBO J. 14:37.
22. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1993. Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc. Natl. Acad. Sci. USA 90:1227.
23. Nelson, C. A., S. J. Petzold, and E. R. Unanue. 1994. Peptides determine the lifespan of MHC class II molecules in the antigen-presenting cell. Nature 371: 250.
24. 19-31. J. Immunol. 156:3815.
25. K. J. Immunol. 157:755.
26. Stem, L. J., J. H. Brown, T. S. Jardetzky, J. C. Gorga, R. G. Urban, J. L. Strominger, and D. C. Wiley. 1994. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368: 215.
27. Ghosh, P., M. Amaya, E. Mellins, and D. C. Wiley. 1995. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378:457.
28. Jardetzky, T. S., J. C. Gorga, R. Busch, J. Rothbard, J. L. Strominger, and D. C. Wiley. 1990. Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9:1797.
29. Murthy, V. L., and L. J. Stern. 1997. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding. Structure 5:1385.
30. Hammer, J., C. Belunis, D. Bolin, J. Papadopoulos, R. Walsky, J. Higelin, W. Danho, F. Sinigaglia, and Z. A. Nagy. 1994. High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc Natl. Acad. Sci. USA 91:4456.
31. Verreck, F. A., C. Vermeulen, A. V. Poel, P. Jorritsma, R. Amons, J. E. Coligan, J. W. Drijfhout, and F. Koning. 1996. The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding. Int. Immunol. 8:397.
32. Chicz, R. M., R. G. Urban, W. S. Lane, J. C. Gorga, L. J. Stern, D. A. Vignali, and J. L. Strominger. 1992. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size. Nature 358:764.
33. Gorga, J. C., V. Horejsi, D. R. Johnson, R. Raghupathy, and J. L. Strominger. 1987. Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. J. Biol. Chem. 262:16087.
34. O'Shannessy, D. J., M. Brigham-Burke, and K. Peck. 1992. Immobilization chemistries suitable for use in the B1Acore surface plasmon resonance detector. Anal. Biochem. 205:132.
35. Hammer, J., P. Valsasnini, K. Tolba, D. Bolin, J. Higelin, B. Takacs, and F. Sinigaglia. 1993. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74:197.
36. O'Sullivan, D., T. Arrhenius, J. Sidney, M. F. Del Guercio, M. Albertson, M. Wall, C. Oseroff, S. Southwood, S. M. Colon, F. C. Gaeta, et al. 1991. On the interaction of promiscuous antigenic peplides with different DR alleles: identification of common structural motifs. J. Immunol. 147:2663.
37. Stumptner, P., and P. Benaroch. 1997 Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region. EMBO J. 16:5807.
38. Fremont, D. H., W. A. Hendrickson, P. Marrack, and J. Kappler. 1996. Structures of an MHC class II molecule with covalently bound single peptides. Science 272:1001.
39. Nozaki, Y., and C. Tanford. 1971. The solubility of amino acids and two glycine peptides in aqueous ethanol and dioxane solutions: establishment of a hydrophobicity scale. J. Biol. Chem. 246:2211.
40. Smith, K. J., J. Pyrdol, L. Gauthier, D. C. Wiley, and K. W. Wucherpfennig. 1998. Crystal structure of HLA-DR2 (DRA*0101. DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 188:1511.
41. Fremont, D. H., D. Monnaie, C. A. Nelson, W. A. Hendrickson, and E. R. Unanue. 1998. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 8:305.
42. Beeson, C., and H. M. McConnell. 1995. Reactions of peptides with class II proteins of the major histocompatibility complex. J. Am. Chem. Soc. 117:10429.
43. Liang, M. L., C. Lee, Y. Xia, and H. M. McConnell. 1996. Molecular modeling and design of invariant chain peptides with altered dissociation kinetics from class II MHC. Biochemistry 35:14734.
44. Weber, D. A., B. D. Evavold, and P. E. Jensen. 1996. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 274:618.
45. Tanford, C. 1991. The Hydrophobic Effect: Formation of Micelles and Biological Membranes. Kreiger, Malabar, FL.
46. Hughson, F. M., Wright, P.E., and Baldwin, R.L. 1990. Structural characterisation of a partly folded apomyoglobin intermediate. Science 249:1544.
47. Kropshofer, H., A. B. Vogt, L. J. Stern, and G. J. Hammerling. 1995. Self-release of CLIP in peptide loading of HLA-DR molecules. Science 270:1357.
48. Malcherek, G., V. Gnau, G. Jung, H. G. Rammensee, and A. Melms. 1995. Supermotifs enable natural invariant chain-derived peptides to interact with many major histocompatibility complex-class II molecules J. Exp. Med. 181:527.
49. Nakarajan, S. K., M. Assadi, and S. Sadegh-Nasseri. 1999. Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. J. Immunol. In press.